Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Primary Clinic (Direct GLP) vs Queen RX

Primary Clinic (Direct GLP)
Graded #219

Lower grade

vs+0.7999999999999972
Queen RX
Graded #192

Higher grade

The verdict

Queen RX takes it — 66.3/100 to 65.5/100, but only just.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo). Primary Clinic (Direct GLP) is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +12
65
77
Dose & formulationQueen RX +3
54
57
Clinical oversightPrimary Clinic (Direct GLP) +6
75
69
Labs & monitoringPrimary Clinic (Direct GLP) +23
76
53
FulfillmentQueen RX +2
73
75
Contract termsQueen RX +20
41
61
Primary Clinic (Direct GLP) · left barQueen RX · right bar

The numbers

MetricPrimary Clinic (Direct GLP)Queen RX
WeighScore65.5/10066.3/100
GradeCC
Scorecard rank#219#192
Semaglutide$85/mo (0.25-0.75 mg band, membership required, compounded)$100/mo (quarterly plan, compounded)
Tirzepatide$133/mo (1.25-2.5 mg band, membership required, compounded)Not disclosed
Coverage10 states45 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only

Strengths

  • Direct Primary Care model integrates GLP-1 with continuous primary care — unlike most direct-to-consumer platforms
  • GLP-1 at wholesale cost with no markup — semaglutide from $65/mo, tirzepatide from $110/mo (members only)
  • Unlimited primary care visits, direct text access, and same-day care bundled in the $89/mo membership
  • Routine labs and thousands of medications included in membership — no surprise bills
  • Per-dose pricing shown publicly for all 8 dose tiers of both semaglutide and tirzepatide

Where it loses points

  • The medication price is on top of an $89/mo direct-primary-care membership, which the FAQ states does not include the drug — all-in is about $174/mo for semaglutide and $222/mo for tirzepatide
  • Prices are published as dose BANDS rather than per dose, and the cheapest tirzepatide band starts at 1.25 mg, below the 2.5 mg labelled starting dose
  • The pricing is rendered entirely in JavaScript, so nothing on the page is readable without running the site's bundle
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Queen RX

Graded #192 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard